12 completed, 4 recruiting, 3 unknown, 1 terminated. 21 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 21 | Completed 12, Recruiting 4, Unknown 3, Terminated 1, Withdrawn 1 |
Follow Fluconazole: new trials by email Literature Review of Fluconazole trials Research Report on Fluconazole
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparing the Efficacy of Oral Fluconazole Versus Oral Itraconazole in Treating Resistant Tinea Corporis Itraconazole (200 mg), Fluconazole 150 mg - Tinea Corporis, Dermatophytosis | Phase 4 | Recruiting | Urooj Fatima | 126 | 2025-11-01 | 2026-01-15 |
| Comparison of Efficacy of Oral Fluconazole Versus Oral Itraconazole in the Treatment of Pityriasis Versicolor Fluconazole, Itraconazole - Pityriasis Versicolor | Phase 4 | Recruiting | Khyber Teaching Hospital | 106 | 2025-03-01 | 2025-04-10 |
| Clinical Trial Testing Whether Targeted Antibiotic Prophylaxis Can Reduce Infections After Cystectomy Compared to Empiric Prophylaxis Pivmecillinam, Amoxicillin clavulanic acid, Amoxicillin - Cystectomy, Bladder Cancer Requiring Cystectomy | Phase 4 | Recruiting | Copenhagen University Hospital, Rigshospitalet | 248 | 2025-01-07 | 2025-01-09 |
| Introduction of Mycotic Prophylaxis At Cystectomy Trial. Fluconazole, Isotonic saline solution - Cystectomy | Phase 4 | Recruiting | Copenhagen University Hospital, Rigshospitalet | 420 | 2024-06-24 | 2026-08-12 |
| Endothelial Derived Hyperpolarization Factor and Vascular Control Fluconazole 150 mg - Healthy | Phase 4 | Unknown | University of Oklahoma | 30 | 2022-02-19 | 2024-07-23 |
| Fluconazol Versus Medical Honey in the Treatment of Recurrent Vulvovaginal Candidiasis Fluconazole, L-Mesitran - Candidiasis, Vulvovaginal, Recurrent Candidiasis of Vagina | Phase 4 | Unknown | Maastricht University Medical Center | 252 | 2021-03-01 | 2020-11-12 |
| Fluconazole Pharmacokinetics, Including Bioavailability, in Obese Subjects After an Intravenous and Oral Administration Fluconazole 200mg tab, Fluconazole 2 MG/ML - Fluconazole, Candidiasis | Phase 4 | Completed | Radboud University Medical Center | 25 | 2019-11-30 | 2021-07-14 |
| Efficacy Study of Fluconazole to Treat Coccidioidomycosis Pneumonia (Valley Fever) Fluconazole, Placebo - Coccidioidomycosis | Phase 4 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 72 | 2015-12-29 | 2019-07-05 |
| Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal Candidiasis Clotrimazole vaginal tablet, Fluconazole - Candidiasis, Vulvovaginal | Phase 4 | Completed | Peking University Shenzhen Hospital | 240 | 2014-07-01 | 2017-05-02 |
| Safety of Fluconazole Treatment of Premature and Full-term Newborn Infants Treatment with fluconazole., 2. Treatment with both fluconazole and Ibuprofen., 3. Treatment with ibuprofen. - Ductus Arteriosis, Patent, Bacterial Infections and Mycoses | Phase 4 | Completed | Anders Rane, MD, PhD, Senior professor | 80 | 2014-04-01 | 2015-09-02 |
| Terconazole Vaginal Suppository vs Fluconazole for the Treatment of Severe Vulvovaginal Candidiasis Terconazole Vaginal Suppository, Fluconazole - Vulvovaginal Candidiasis | Phase 4 | Completed | Peking University Shenzhen Hospital | 140 | 2013-08-01 | 2020-10-23 |
| Operational Research for Cryptococcal Antigen Screening Fluconazole - Cryptococcal Meningitis, Cryptococcus Neoformans | Phase 4 | Completed | University of Minnesota | 3049 | 2012-07-01 | 2020-06-04 |
| Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients Anidulafungin, Fluconazole - Mycoses, Fungemia | Phase 4 | Completed | University of Pittsburgh | 200 | 2010-02-01 | 2014-12-17 |
| Clinical Significance of Smear or Culture Positive for Candida Spp. From Sputum Three Times a Week fluconazole - Pulmonary Candidiasis | Phase 4 | Unknown | Capital Medical University | 200 | 2007-09-01 | 2010-12-14 |
| Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive Candidiasis Eraxis (anidulafungin), Diflucan (fluconazole), Vfend (voriconazole) - Candidiasis | Phase 4 | Completed | Pfizer | 282 | 2007-07-01 | 2011-10-03 |
| Single Dose Versus Two Weeks Course of Fluconazole in the Treatment of Oropharyngeal Candidiasis in HIV Infected Individuals in Tanzania fluconazole - Oropharyngeal Candidiasis | Phase 4 | Completed | Netherlands Organisation for Scientific Research | 220 | 2006-11-01 | 2008-05-07 |
| Fluconazole Versus Micafungin for Candida Bloodstream Infection in Non-Neutropenic Patients Fluconazole, Micafungin - Candidiasis, Sepsis | Phase 4 | Withdrawn | Kyoto University | 2006-08-01 | 2024-06-14 | |
| Effects of Nevirapine on the Steady State Pharmacokinetics of Fluconazole in HIV Positive Patients Fluconazole, Nevirapine - HIV Infections | Phase 4 | Completed | Boehringer Ingelheim | 24 | 2001-05-01 | 2014-07-14 |
| Fluconazole Prophylaxis of Thrush in AIDS fluconazole - Acquired Immunodeficiency Syndrome, Candidiasis | Phase 4 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 80 | 1996-07-01 | 2008-03-04 |
| A Study to Compare the Use of Fluconazole as Continuous Therapy Versus Periodic Therapy in HIV-Positive Patients With Recurrent Thrush Fluconazole - Candidiasis, Oral, HIV Infections | Phase 4 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 948 | 2021-10-29 |
Showing 20 of 21. Sign in to see all of them.
Candidiasis (5) · Candidiasis, Vulvovaginal (3) · Acquired Immunodeficiency Syndrome (2) · Candidiasis, Oral (2) · HIV Infections (2) · Mycoses (2) · AIDS-Related Opportunistic Infections (1) · Bacterial Infections and Mycoses (1) · Candidemia (1) · Candidiasis, Invasive (1) · Central Nervous System Fungal Infections (1) · Coccidioidomycosis (1) · Community-Acquired Pneumonia (1) · Cryptococcosis (1) · Fungemia (1)
National Institute of Allergy and Infectious Diseases (NIAID) (4) · Copenhagen University Hospital, Rigshospitalet (2) · Peking University Shenzhen Hospital (2) · Anders Rane, MD, PhD, Senior professor (1) · Boehringer Ingelheim (1) · Capital Medical University (1) · Khyber Teaching Hospital (1) · Kyoto University (1) · Maastricht University Medical Center (1) · Netherlands Organisation for Scientific Research (1) · Pfizer (1) · Radboud University Medical Center (1) · University of Minnesota (1) · University of Oklahoma (1) · University of Pittsburgh (1)
United States (7) · China (3) · Denmark (2) · Pakistan (2) · Japan (1) · Netherlands (1) · Puerto Rico (1) · South Korea (1) · Sweden (1) · Tanzania (1) · Uganda (1)
Shangrong Fan, M.D. (2) · Anders Rane, Prof. MD (1) · Bin Cao, Doctor (1) · David B Meya, MMed (1) · Ferdinand Mugusi, MD,MMED (1) · Jeremy M Kellawan, PhD (1) · Mecky IN Matee, PhD (1) · Mitchell Goldman (1) · Nina Singh, MD (1) · Omar JM Hamza, DDS (1) · Paul E Verweij, PhD (1)
PMID 17651612, PMID 18840077, PMID 19144094, PMID 24559321, PMID 25376267, PMID 25877666, PMID 26050015, PMID 27073145, PMID 28459966, PMID 28597967, PMID 30399034, PMID 31280481, PMID 33891293, PMID 40722189, PMID 41420405, PMID 42380957
2023 (1), U01GH000517 (1)